VivoSim Labs
VIVS
123 hedge funds and large institutions have $37M invested in VivoSim Labs in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 46 reducing their positions, and 19 closing their positions.
26% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 19
3% more funds holding
Funds holding: 119 → 123 (+4)
0% less ownership
Funds ownership: 0.11% → 0.11% (-0%)
40% less capital invested
Capital invested by funds: $61.4M → $37M (-$24.4M)
52% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 46
96% less call options, than puts
Call options by funds: $14K | Put options by funds: $354K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$5.06M |
| 2 |
Bank of New York Mellon
New York
|
+$377K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$325K |
| 4 |
Millennium Management
New York
|
+$311K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$151K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.7M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.02M |
| 3 |
Renaissance Technologies
New York
|
-$524K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$394K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$364K |
VIVS Hedge Fund Activity: Q4 2017 in Review
123 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2017, worth a combined $37M — down 40% from $61.4M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new VIVS positions and 19 closed out — a net gain of 5 holders — while 22 added to existing stakes and 46 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $5.06M. The largest seller was BlackRock, cutting an estimated $2.7M.
- 123 institutional investors held VivoSim Labs (VIVS) as of Q4 2017, up from 119 in Q3 2017.
- Funds reported $37M of VivoSim Labs stock for Q4 2017, down 40% quarter-over-quarter.
- 24 funds opened new VivoSim Labs positions in Q4 2017 and 19 closed out, a net change of +5 holders.
- The largest VivoSim Labs buyer in Q4 2017 was ARK Investment Management, an estimated $5.06M added.
- The largest VivoSim Labs seller in Q4 2017 was BlackRock, an estimated $2.7M sold.
Based on aggregated 13F filings for Q4 2017.